Research
Cellular
GLP-1 RA therapy was associated with a low rate of major adverse events in LVAD patients.
GLP-1 RA appears to be a safe adjunct therapy for LVAD patients.
StrongSupportsmedium confidence
GLP-1 RA therapy was not associated with cannula position change... LVADs complication rate was relatively low.
Why this rating
Based on a retrospective analysis of patient outcomes.
Source
Glucagon‐Like Peptide‐1 Receptor Agonists in Patients With Durable Left Ventricular Assist Devices
B. Elad et al. · Artificial Organs · 2025
DOI 10.1111/aor.14942
cohort · n=40Cited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →